Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 1595888 NEW YORK, NY
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$154,267
-$745,099 QoQ
Shares Held
17,314
-83.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 120 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Derivatives in KYTX

reported options exposure · as of Jun 30, 2026
CallValue
$176,418
CallShares
19,800
PutValue
$245,025
PutShares
27,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. KYTX ranks #183 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in KYTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $176,418 19,800
2026-06-30 $245,025 27,500
2026-06-30 $154,267 17,314
2026-03-31 $899,366 104,214
2026-03-31 $133,765 15,500
2025-12-31 $1,711,673 182,093
2025-12-31 $124,080 13,200
2025-12-31 $515,120 54,800
2025-09-30 $1,193,106 198,851
2025-09-30 $90,000 15,000
2025-06-30 $269,449 87,769
2024-09-30 $191,652 39,193
2024-06-30 $164,835 21,978
2024-03-31 $920,098 37,041